Tags: Chemical Compound, Chemical Substance.

AZD1305 is an experimental drug candidate that is under investigation for the management and reversal of cardiac arrhythmias specifically atrial fibrillation and flutter. In vitro studies have shown that this combined-ion channel blocker inhibits rapidly the activating delayed-rectifier potassium current (IKr) L-type calcium current and inward sodium current (INa).

AZD-1305.svg
IUPAC name
2-Methyl-2-propanyl (2-7-[2-(4-cyano-2-fluorophenoxy)ethyl]-9-oxa-37-diazabicyclo[3.3.1]non-3-ylethyl)carbamate

Loading...

This page contains content from the copyrighted Wikipedia article "AZD1305"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.